Literature DB >> 17283582

Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups.

A Mak1, C C Mok, W P Chu, C H To, S N Wong, T C Au.   

Abstract

The objective of this study was to compare the frequency and severity of renal damage in systemic lupus erythematosus (SLE) with regard to the age of disease onset. Among 287 patients with new onset SLE diagnosed between 1991 and 2003 in our hospital, we identified those who fulfilled the American College of Rheumatology (ACR) criteria for renal involvement. Patients were categorized into childhood (age < 16 [corrected] years), adult (between 16 and 50 years) or late onset ( > or = 50 years) SLE. Clinical presentation of renal disease and cumulative renal damage as assessed by the renal domain of the Systemic Lupus International Collaborating Clinics/ACR damage index (SDI) were compared. A linear regression model was constructed to study the effect of age on renal damage. One-hundred and forty-nine patients were studied (134 women and 15 men), including 28 childhood, 107 adult and 14 late onset SLE patients. The mean age of SLE onset was 29.7 +/- 14 years. The prevalence of renal disease was 53% in childhood onset, 50% in adult onset and 58% in late onset SLE patients (P = 0.66). At renal disease presentation, late onset SLE patients had significantly lower creatinine clearance and were more likely to be hypertensive. Histological classes of nephritis and initial treatment response, however, did not differ significantly among the patients. After a mean observation of 80.3 months, 32 (21%) patients developed renal damage (renal SDI > or = 1). Late onset SLE patients had accrued more renal damage than the others. In a multiple regression model, age was not a significant determinant of renal damage after adjustment for baseline renal parameters, duration of renal disease, use of cyclophosphamide and initial treatment response. We concluded that the prevalence of renal disease was similar among SLE patients of different ages of onset. Late onset SLE patients had accrued more renal damage but age did not correlate with renal damage after adjustment for various clinical parameters.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17283582     DOI: 10.1177/0961203306074469

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  28 in total

1.  Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients.

Authors:  Zheng Tang; Dongmei Chen; Shengmei Yang; Haitao Zhang; Weixin Hu; Zhihong Liu; Leishi Li
Journal:  Rheumatol Int       Date:  2010-06-10       Impact factor: 2.631

Review 2.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

Review 3.  Lupus nephritis in Colombians: contrasts and comparisons with other populations.

Authors:  Juan-Manuel Anaya; Carlos Cañas; Rubén D Mantilla; Ricardo Pineda-Tamayo; Gabriel J Tobón; Catalina Herrera-Diaz; Diego M Rendón; Adriana Rojas-Villarraga; Mauricio Uribe
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

4.  Comparison of clinical, serological, and prognostic differences among juvenile-, adult-, and late-onset lupus nephritis in Korean patients.

Authors:  Ji-Hyoun Kang; Dong-Jin Park; Kyung-Eun Lee; Ji Shin Lee; Yoo-Duk Choi; Shin-Seok Lee
Journal:  Clin Rheumatol       Date:  2017-04-25       Impact factor: 2.980

5.  Outcome and predictors of kidney disease progression in Puerto Ricans with systemic lupus erythematosus initially presenting with mild renal involvement.

Authors:  Mariely Nieves-Plaza; Ana P Ortiz; Marilú Colón; María J Molina; Lesliane E Castro-Santana; Vanessa E Rodríguez; Angel M Mayor; Luis M Vilá
Journal:  J Clin Rheumatol       Date:  2011-06       Impact factor: 3.517

6.  Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study.

Authors:  Abdulla Watad; Arsalan Abu Much; Danielle Bracco; Naim Mahroum; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

7.  Renal function assessment in patients with systemic lupus erythematosus.

Authors:  Marco Ulises Martínez-Martínez; Jaime Antonio Borjas-García; Martín Magaña-Aquino; Enrique Cuevas-Orta; Lilia Llamazares-Azuara; Carlos Abud-Mendoza
Journal:  Rheumatol Int       Date:  2011-05-21       Impact factor: 2.631

8.  Identification of unique microRNA signature associated with lupus nephritis.

Authors:  Jeannie L Te; Igor M Dozmorov; Joel M Guthridge; Kim L Nguyen; Joshua W Cavett; Jennifer A Kelly; Gail R Bruner; John B Harley; Joshua O Ojwang
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

Review 9.  Use of biomarkers in the management of children with lupus.

Authors:  Elisabeth Binder; Monika Edelbauer
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

10.  DNase1 activity in systemic lupus erythematosus patients with and without nephropathy.

Authors:  Fernando Martinez-Valle; Eva Balada; Josep Ordi-Ros; Segundo Bujan-Rivas; Agustin Sellas-Fernandez; Miquel Vilardell-Tarres
Journal:  Rheumatol Int       Date:  2009-10-21       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.